Croatia vs Eastern and South-Eastern Asia: Percentage of bloodstream infection due to methicillin-resistant
Croatia
53.8%
in 2022
Eastern and South-Eastern Asia
41.3%
in 2022
Croatia rank
9th
Eastern and South-Eastern Asia rank
9th
Percentage of bloodstream infection due to methicillin-resistant over time
- Croatia
- Eastern and South-Eastern Asia
How they compare
Croatia currently reports 53.8% against 41.3% in Eastern and South-Eastern Asia, a difference of 12.5%.
That makes Croatia's figure about 1.3 times Eastern and South-Eastern Asia's.
The two have swapped places 2 times across 6 shared years of data; in 2017 it was Croatia ahead.
Croatia ranks 9th and Eastern and South-Eastern Asia ranks 9th of 50 countries.
Across the 2 decades both report, Croatia averaged higher in 1 and Eastern and South-Eastern Asia in 1.
Head to head by decade
| Decade | Croatia | Eastern and South-Eastern Asia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 26.6% | 32.9% | 6.4% | Eastern and South-Eastern Asia |
| 2020s | 56.8% | 37.5% | 19.3% | Croatia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Croatia or Eastern and South-Eastern Asia?
- Croatia, at 53.8% against 41.3% in Eastern and South-Eastern Asia as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Croatia and Eastern and South-Eastern Asia?
- 12.5%, with Croatia ahead.
- How many years of comparable data are there for Croatia and Eastern and South-Eastern Asia?
- 6 years are reported by both, from 2017 to 2022.
- How do Croatia and Eastern and South-Eastern Asia rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Croatia ranks 9th and Eastern and South-Eastern Asia ranks 9th of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.